Dr Dane Cheasley
Honorary Conjoint Fellow
The Sir Peter MacCallum Department of Oncology
31 Scholarly works
3 Projects
HIGHLIGHTS
2026
Journal article
Breast cancers arising in high mammographic density tissue harbor tumor-promoting immune profiles
DOI: 10.1038/s41523-025-00884-y2026
Journal article
A scalable, multi-resolution consensus clustering approach for prioritizing robust signals from high-throughput screens
DOI: 10.1093/bib/bbag2422026
Journal article
Differential Preclinical Efficacy of Combined CDK4/6 and MEK Inhibition in Low-Grade Serous Ovarian Carcinoma Based on KRAS/NF1 Mutational Status
DOI: 10.3390/ijms270417742026
Journal article
Identifying therapeutic targets in low-grade serous ovarian carcinomas with no specific molecular profile
DOI: 10.1002/path.700752025
Journal article
Assessment of candidate high-grade serous ovarian carcinoma predisposition genes through integrated germline and tumour sequencing
DOI: 10.1038/s41525-024-00447-32024
Journal article
High-throughput drug screening identifies novel therapeutics for Low Grade Serous Ovarian Carcinoma
DOI: 10.1038/s41597-024-03869-x2020
Research grants (ARC, NHMRC, MRFF)
High Throughput Discovery of Synergistic Drug Combinations for Patients With Low-Grade Serous Ovarian Cancer
RECENT SCHOLARLY WORKS
2024
Journal article
Molecular Surrogate Subtypes of Ovarian and Peritoneal Low-grade Serous Carcinoma
DOI: 10.1097/PGP.00000000000010432022
Journal article
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
DOI: 10.1158/1078-0432.CCR-22-12062022
Journal article
Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression
DOI: 10.1038/s41698-022-00288-22021
Journal article
Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control study
DOI: 10.1038/s41523-021-00279-9
RECENT PROJECTS
2020
Research grants (ARC, NHMRC, MRFF)
High Throughput Discovery of Synergistic Drug Combinations for Patients With Low-Grade Serous Ovarian Cancer
2016
Research Grant
Improving Early Detection and Management of Women at Risk of Developing Interval Breast Cancer